EXHIBIT 99.1 Cronos Group Inc. Cronos Group’s portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™. Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021 PRESS RELEASE GlobeNewswire May. 2018 - Consolidated Financial Statements. Cronos Group does not currently have any hardcopy reports on AnnualReports.com. Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K (this “Annual Report”) to the “Company”, “Cronos Group”, “we”, “us” and “our” refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term “cannabis” means the … For financial reporting, their fiscal year ends on December 31st. Minimum 15 minutes delayed. 26 March 2019. Please fill out the form below and click "Place Order" to complete your order. With international production and distribution across five continents. Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. Inside Cronos Group Inc.'s 10-K Annual Report: Financial - Earnings Highlight. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2020 fourth quarter and full-year business results. Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021, 2021 Annual and Special Meeting of Shareholders. Cronos Group (CRON) is in the Danger Zone. Announces Results of Vote for Election of Directors TORONTO, June 19, 2019 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 shareholders voting in person or by proxy holding in total … 2018 - Q3 Interim Condensed Financial Statements. 2017 – Annual Information Form. Cronos Group annual revenue increased from $15.7 million in 2018 to $23.8 million in 2019, a (51.2%) increase. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. © 2021 The Cronos Group, All rights reserved. 2018 - Q3 Management’s Discussion and Analysis (MD&A) 529.9 KB. 2018 – Annual Information Form. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group Inc. annual income statement. Cronos Group Contact Shayne Laidlaw Tel: (416) 504-0004 investor.relations@thecronosgroup.com News Provided by GlobeNewswire via QuoteMedia Cannabis - Will The Fortune 500 Join The Party? Data Provided by Refinitiv. Cronos Group Inc. (NASDAQ: CRON) today announces its 2019 fourth quarter and full-year business results. Financial - Cash Flow Highlight We also provide access without charge to all of our SEC filings, including copies of this Annual Report, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after filing or furnishing, on our website … There's no guarantee that Cronos Group will actually file its annual report to the SEC and provide a Q4 update within the next 15 days. Click the button below to request a report when hardcopies become available. Canada, and Original BC Ltd. (British Columbia), which is based in the Okanagan Valley. Gain on disposal of investments. The Audit Committee of the Cronos Group Board of Directors has completed its review of certain bulk resin purchases and sales of products through the wholesale channel. 2018 - Year End Management’s Discussion and Analysis (MD&A) 27 April 2018. Cronos Group (NASDAQ:CRON) is down 2.7% after hours after notifying that its complete annual report will be late. At this point, it … 2018 - Year End Management’s Discussion and Analysis (MD&A) 329.1 KB. Cronos Group Inc. today announces its 2021 First Quarter business results. Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K (the “Annual Report”) to the “Company”, “Cronos Group”, “we”, “us” and “our” refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term “cannabis” means the … Shipping Information. This page shows recent SEC filings related to Cronos Group Inc. In Full-Year 2019, Cronos Group recorded a pre-tax gain of $21.5 million primarily related to the disposal of shares in … Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. Q3. April 28 | 2021. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Cronos Group Inc.. Name Email Street Address City State (USA Only) Find detailed stats on Cronos Group revenue on Craft. Cronos Group announced it's 2019 fourth quarter and full year financial results. Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K/A (the “Annual Report”) to the “Company”, “Cronos Group”, “we”, “us” and “our” refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term … These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. The Company has multiple international production and distribution platforms: Cronos Israel and Cronos Australia. Misleading Earnings From 2017 to the trailing twelve months (TTM) period, CRON’s net income improved from $2 million to $498 million. 26 March 2019. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. 487.3 KB. 2019 – Annual Report. United States Results Cronos Group’s U.S. reporting segment includes results ... see Note 14 to the consolidated financial statements in Item 8 of the Company's Annual Report … Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2020 third quarter business results. The Company operates two wholly-owned Canadian Licensed Producers regulated under Health Canada’s Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc. (Ontario), which was the first non-incumbent medical cannabis license granted by Health. Cronos Group’s Rest of World reporting segment includes results of the Company’s operations for all markets outside of the U.S. (in thousands of … Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Annual Meeting of … “The opportunities before Cronos Group are more exciting than ever and I am honored to have brought the company to this important inflection point as we bring on Kurt Schmidt to serve as our new President and CEO,” … 10, 2021, 01:00 PM Please fill out the form below and click "Place Order" to complete your order. 26 March 2019. Cronos Group Inc is primarely in the business of medicinal chemicals & botanical products. For FY 2020, we reported an adjusted earnings (loss) before interest, taxes, depreciation and amortization ("Adjusted EBITDA") of $(147.3) million, representing a decrease in Adjusted EBITDA of $48.9 million from FY 2019. View CRON financial statements in full, including balance sheets and ratios. Cronos Group $ (111,233) $ 62,005 Non-controlling interests (479) (435) $ (111,712) $ 61,570 Other comprehensive income (loss) Foreign exchange gain (loss) on translation $ 50,605 $ 28,263 Total other comprehensive income (loss) 50,605 28,263 Comprehensive income (loss) (61,107) 89,833 Comprehensive income (loss) attributable to: Cronos Group (60,414) 90,285 Cronos Group’s United States reporting segment includes results of the Company’s operations for all brands and products in the United States of America. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group Inc. Mailing Address: 111 Peter Street Unit 300 Toronto, Ontario M5V2H1: Head Office Address: 111 Peter Street Unit 300 Toronto, Ontario M5V2H1: Contact Name: Xiuming Shum: Principal Regulator: Ontario: Business e-mail address: corporate.secretary@thecronosgroup.com: Short Form Prospectus Issuer: Yes: Telephone … Cronos Group does not currently have any hardcopy reports on AnnualReports.com. “Our fourth quarter 2020 results are the summation of the hard work and perseverance the Company has put into this past year despite the challenges of 2020. Click the button below to request a report when hardcopies become available. 2018 - Year End Consolidated Financial Statements. 215.2 KB. Cronos Group is an innovative global cannabinoid company With international production and distribution across five continents. Through an exclusive distribution agreement, Cronos also has access to over 12,000 pharmacies in Germany as the Company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.